Leadership. Empowerment. Development.

LEAD is a 2-day conference designed for women in oncology and hematology. The goal of this conference is to empower women leaders in the hematology and oncology space by providing essential clinical updates, career development, and professional networking. Sessions include discussions on the importance of women’s leadership, career development workshops, and clinical sessions on biomarkers and oncology therapies.

*Program is subject to change prior to conference.

Day 1: October 4, 2019

7:00 AM—8:00 AM

Breakfast and Registration

One-on-One Mentoring Sessions

8:00 AM—8:05 AM

Welcome Remarks and Conference Overview

Plenary Session: The Importance of Women’s Leadership in Healthcare and Oncology

8:05 AM – 9:30 AM

Professional Vignettes and Panel Discussion: Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology

Linda Bosserman, MD | City of Hope
Vicki Goodman, MD | Bristol-Myers Squibb
Nicole Gormley, MD | US Food and Drug Administration
Sandra Horning | Roche/Genentech
Joyce O’Shaughnessy, MD | Texas Oncology

9:20 AM – 9:30 AM

Panel Discussion and Participant Q&A

Chair and Session Speakers

Session I: Focused Workshops, Part 1

9:30 AM – 10:15 AM

Burnout or Balance?
Finding Resilience in an Age of Chronic Stress

Barrett McBride, PhD

10:15 AM – 10:30 AM

Break

10:30 AM – 11:30 AM

Panel: Building Your Resiliency and Relationship Success

Moderator: Barrett McBride, PhD

Charu Aggarwal, MD, MPH | U. of Pennsylvania
Julie Brahmer, MD, MSc | Johns Hopkins Medicine
Elizabeth Comen, MD | Memorial Sloan Kettering
Alessandra Ferrajoli, MD | MD Anderson
Joyce O’Shaughnessy, MD | Texas Oncology
Rachna Shroff, MD |U. of Arizona Cancer Center

11:30 AM – 12:15 PM

A Social Media Toolkit to Enhance Your Career

Moderator: Shikha Jain, MD | Rush U. Medical Center

Stephanie Graff, MD | Menorah Medical Center
Tiffany Traina, MD | Memorial Sloan Kettering

12:15 PM – 1:30 PM

Lunch

12:30 PM – 1:30 PM

Industry Product Theater

Session II: Impact of Emerging Biomarkers on Treatment Selection and Drug Development

1:30 PM – 1:50 PM

The Role of Biomarkers in the Development of PARP Inhibitors

Joyce O’Shaughnessy, MD | Texas Oncology

1:50 PM – 2:10 PM

When Biomarkers Define Indication – MSI, MMR, and Mutations

Rachna Shroff, MD | U. of Arizona Cancer Center

2:10 PM – 2:30 PM

Challenges with Biomarkers in Cancer Drug Development

Lauren Byers, MD | MD Anderson

2:30 PM – 2:45 PM

Panel Discussion and Participant Q&A

Chair and Session Speakers

2:45 PM – 3:15 PM

Break

Session III and IV: Clinical Updates in Immuno-Oncology and Cell-based Therapies

3:15 PM – 3:35 PM

Patient Selection in Frontline Metastatic Lung Cancer

Julie Brahmer, MD, MSc | Johns Hopkins Medicine

3:35 PM – 3:55 PM

CAR T Cell Therapy: New Era of Therapy for B-Cell Malignancies

Julie Vose, MD, MBA | U. of Nebraska Medical Center

3:55 PM – 4:15 PM

Targeted Tumor Treatment with Antibody Drug Conjugates

Sarah Hurvitz, MD | UCLA

4:15 PM – 4:35 PM

Antibody Therapy as an Evolving SOC in Multiple Myeloma

Nina Shah, MD | UCSF

4:35 PM – 4:50 PM

Panel Discussion and Participant Q&A

4:50 PM – 5:25 PM

Immunotherapy for PD-L1 Positive or MSI-high Cervical Cancer 


Addressing Unmet Clinical Needs in Advanced Ovarian Cancer

Claire Friedman, MD | Memorial Sloan Kettering

5:25 PM – 5:45 PM

Treatment Evolution in Triple Negative Breast

Tiffany Traina, MD | Memorial Sloan Kettering

5:45 PM – 6:00 PM

Panel Discussion and Participant Q&A

Chair and Session Speakers

6:00 PM – 7:00 PM

Evening Networking Reception

 

Day 2: October 5, 2019

6:30 AM – 7:30 AM

Sunrise Yoga

8:00 AM – 8:30 AM

Breakfast

One-on-One Mentoring Sessions

Session V: Clinical Updates in Small-Molecule Targeted Inhibitors

8:30 AM – 8:50 AM

CLL: Reaching for Curative Potential

Alessandra Ferrajoli, MD | MD Anderson

8:50 AM – 9:10 AM

Targeted Inhibitors in EGFR-positive Lung Cancer

Leora Horn, MD, MSc, FRCPR | Vanderbilt Ingram Cancer Ctr

9:10 AM – 9:30 AM

Moving Beyond Checkpoint Inhibitors: New Treatment Options in Urothelial Cancer

Arlene Siefker-Radtke, MD | MD Anderson

9:30 AM – 9:45 AM

Panel Discussion and Participant Q&A

Chair and Session Speakers

Session VI: Patient Management and Supportive Care in an Era of New Therapies

9:45 AM – 10:05 AM

Financial and Quality of Life Impact of Early Supportive Care

Monica Malec, MD | U. of Chicago

10:05 AM – 10:25 AM

Sexual Health and Fertility After Cancer Treatment for Women

Anne Katz, PhD, RN | CancerCare Manitoba

10:25 PM – 10:45 AM

Redefining Value with Modern Cancer Therapies

Debra Patt, MD, MPH, MBA | US Oncology

10:45 AM – 11:00 AM

Panel Discussion and Participant Q&A

Chair and Session Speakers

11:00 AM – 11:20 AM

Break

Session VII: Focused Workshops, Part 2

11:20 AM – 12:05 PM

Panel: Building Your Brand

Moderator: Nina Shah, MD | UCSF

Charu Aggarwal, MD, MPH | U. of Pennsylvania
Stephanie Graff, MD | Menorah Medical Center
Shikha Jain, MD | Rush U. Medical Center

12:05 PM – 12:50 PM

Panel: Leaning Into Leadership Opportunities

Moderator: Julie Vose, MD, MBA | U. of Nebraska Medical Center

Linda Bosserman, MD | City of Hope

Leora Horn, MD, MSc, FRCPC | Vanderbilt Ingram Cancer Ctr

Jane Meisel, MD | Emory U. Winship Cancer Inst.

12:50 PM – 1:50 PM

Lunch

12:50 PM – 1:50 PM

Industry Product Theater

Session VIII: Focused Workshops, Part 3

1:50 PM – 3:20 PM

Transformational Leadership

Margaret Moore, MBA | Wellcoaches Corporation

3:20 PM – 3:50 PM

Keynote – Future of Women in Oncology

Julie Vose, MD, MBA | U. of Nebraska Medical Center

3:50 PM – 4:00 PM

Award Presentations: Woman Oncologist of the Year and Rising Star

Sponsored by Women Leaders in Oncology

Closing Remarks and Adjourn